CON-TGO91-147 - Seqirus Pty Ltd
Product names
- AUST R 175178 - VERSATIS® lidocaine (lignocaine) 5% w/w dermal patch
Sponsor
Decision Date
Duration
The consent is effective for all batches manufactured from 1 September 2020 until 31 December 2020.
Non-compliance with standard
The product(s) do not conform with the requirements of TGO 91 but are supplied with label(s) that have been approved by the TGA.
Supply/Import or Export
Supply
Therapeutic good type
Prescription medicines